Discover
Entyvio (vedolizumab) / TakedaEARLY-CD: ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice (clinicaltrials.gov) - Apr 16, 2020 - P; N=140; Not yet recruiting; Sponsor: Takeda
Amjevita (adalimumab biosimilar) / Amgen, Daiichi SankyoAmgevita approved in Colombia (GaBI) - Apr 17, 2020 - "Amgen’s Amgevita (ABP 501) is the first producto bioterapéutico similar to be approved in Colombia for the treatment of complex diseases such as rheumatoid arthritis, Crohn’s disease and psoriasis."
Stelara (ustekinumab) / J&JSMC accepts four medicines for NHS use (PharmaTimes) - Apr 14, 2020 - "Janssen's Stelara (ustekinumab) was endorsed by the SMC for the treatment of moderately to severely active ulcerative colitis...Stelara offers another treatment option and may help some patients to delay or avoid the need for surgery, the agency noted."
